Lupin gets USFDA nod for Pitavastatin tabletsThe company has received tentative approval from the United States Food and Drug Administration (USFDA) to market its Pitavastatin tablets.
30 Dec, 2016, 05.51 PM IST
Lupin launches generic Niaspan tablets in US marketThe company's US subsidiary, Lupin Pharmaceuticals Inc has launched the generic Niaspan tablets in multiple strengths of 500mg, 750 mg & 10...
21 Mar, 2014, 04.30 PM IST
Lupin gains on tentative USFDA nod for Niacin oral tabletsThe pharmaceutical major has got tentative USFDA approval to sell Niacin oral tablets of strength 500, 750 and 1000 mg in the US market.
01 Jan, 2014, 10.36 AM IST
New US norms on statins to help Indian drug firmsCholesterol-reducing drugs worth nearly $15 billion (Rs 92,000 crore) were sold in the US in the year to September 2013, Bakhru wrote in hi...
01 Jan, 2014, 04.06 AM IST
Lupin launches generic Fenofibric Acid capsules in US marketLupin said its US arm has launched generic Fenofibric Acid capsules used for reducing cholesterol and fatty acids in the blood in the Ameri...
06 Dec, 2013, 02.18 PM IST
Lupin gets USFDA nod for additional strengths of cholesterol drug"Lupin Pharmaceuticals Inc (LPI), the company's US subsidiary would commence marketing the product shortly," Lupin said.
22 Oct, 2013, 03.20 PM IST
Lupin falls nearly 5% on Mylan drug launch, Credit Suisse downgradeCredit Suisse downgraded Lupin from ‘outperform’ to ‘neutral’ rating and upped the price target from Rs 710 earlier to Rs 755.
20 May, 2013, 11.07 AM IST
Lupin launches generic Tricor in the USLupin has launched generic version of Tricor in the US market after getting approval from the US Food and Drug Administration.
26 Nov, 2012, 05.03 PM IST
- Lupin gets USFDA nod for generic cholesterol drug
The US health regulator has granted approval to Lupin to market generic Fenofibrate Tablets, a cholesterol lowering drug, in the American m...
29 Dec, 2011, 07.39 PM IST
- Lupin's cholesterol-lowering drug Perindopril recalled in US; stock up
The US Food and Drug Administration (USFDA) has recalled all lots of Lupin Pharma’s cholesterol-lowering drug perindopril for “not meeting ...
20 Apr, 2011, 10.00 AM IST
- Lupin’s cholesterol-lowering drug Perindopril recalled in US
US Food and Drug Administration (USFDA) has recalled all lots of Lupin Pharma’s cholesterol-lowering drug perindopril for “not meeting spec...
20 Apr, 2011, 06.23 AM IST
- Lupin files second suit against Ranbaxy
Mumbai-based drugmaker Lupin has filed a second suit in the US against Ranbaxy Laboratories to prevent the country’s largest drugmaker from...
06 Apr, 2011, 05.02 AM IST
- Lupin drags Ranbaxy to US court over patent violation
Pharma major Lupin Ltd has filed a legal suit against rival Ranbaxy in the US, alleging patent violation of its cholesterol-lowering drug, ...
09 Aug, 2010, 10.26 PM IST
- GeNext to prescribe new growth formula for Lupin
Desh Bandhu Gupta built Lupin into a $1-billion enterprise, but he will chart the journey to $3 billion and beyond with his two children.
15 May, 2010, 12.14 AM IST
- Stocks to watch: Bharti Airtel, Mahindra Satyam, Lupin, Gammon India, Bharti Shipyard, Abott, Solvay
Crude oil prices were steady on Tuesday ahead of the US inventory data. US crude futures for November gained to $66.92 per barrel. London B...
29 Sep, 2009, 09.41 AM IST
- Lupin buys US rights of anti-cholesterol drug Antara for $39 mn
Lupin has bought the US marketing rights and inventory for cholesterol-lowering drug Antara from the bankrupt Oscient Pharma for $39 millio...
29 Sep, 2009, 12.17 AM IST
- Lupin sends notice to Oscient over cholesterol generic
Indian pharma major Lupin has sent a legal notice to US-based Oscient Pharmaceuticals to inform them that they are seeking regulatory appro...
05 Dec, 2008, 12.08 AM IST